Pharma Jobs: PRODUCTION CHEMIST

Company: Stellar Formulations Industries Private Limited
Qualification: B.Pharm, M.Pharm
Experience: 5 to 8
location: Baroda / Vadodara
Ref: 21460327
Summary: B. Pharmacy/ M. Pharmacy. Must have 5-8 years of experience in the pharmaceutical industry (formulations). Experience in handling solid dosage formulations....
Read more: PRODUCTION CHEMIST

Pharma Reviews: Drug associations boycott pharma department's meeting on drug prices control

The Indian pharmaceutical Alliance (IPA) that represents top drug companies, Indian Drugs' Manufacturing Association (IDMA), Organisation of ...
Read more: Drug associations boycott pharma department's meeting on drug prices control

Pharma Reviews: Packaging must drive product innovation

Let's take an example of a pharma company in Goa, which has to transport its product in Northern India. Consider this product to be sensitive such that ...
Read more: Packaging must drive product innovation

US FDA News: FDA approves new treatment for adults with mantle cell lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.
Read more: FDA approves new treatment for adults with mantle cell lymphoma

US FDA News: FDA takes unprecedented step toward more efficient global pharmaceutical manufacturing inspections

The U.S. Food and Drug Administration has determined the agency will recognize eight European drug regulatory authorities as capable of conducting inspections of manufacturing facilities that meet FDA requirements. The eight regulatory authorities found to be capable are those located in: Austria, Croatia, France, Italy, Malta, Spain, Sweden and the United Kingdom.
Read more: FDA takes unprecedented step toward more efficient global pharmaceutical manufacturing inspections

Pharma Reviews: Lupin Q2 Earnings Meet Estimates Despite Pricing Pressure In The US

The Indian pharmaceutical sector has seen pricing pressure in the U.S. due to regulatory issues. “In Q2 we have recorded strong growth in all our ...
Read more: Lupin Q2 Earnings Meet Estimates Despite Pricing Pressure In The US

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new strategies for addressing the crisis of opioid addiction through innovation in packaging, storage and disposal

Statement by FDA Commissioner Gottlieb on new strategies for addressing the opioid addiction crisis.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new strategies for addressing the crisis of opioid addiction through innovation in packaging, storage and disposal

Pharma Reviews: Indian markets attractive for investors with medium to long-term view: Siddharth Bothra, Motilal ...

Indian markets attractive for investors with medium to long-term view: ... The OMC call has worked because this was the industry which was coming out of ... that there could be a turnaround play when it comes to pharmaceuticals.
Read more: Indian markets attractive for investors with medium to long-term view: Siddharth Bothra, Motilal ...

US FDA News: Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease
Read more: Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

Pharma Reviews: Govt moves to finalize methodology to fix prices of new drugs

The department of pharmaceuticals has called a meeting with industry ... D.G. Shah, secretary general of the Indian Pharmaceutical Alliance (IPA), ...
Read more: Govt moves to finalize methodology to fix prices of new drugs

Pharma Reviews: Indian-American billionaire charged with leading pharmaceutical fraud scheme in US

By Lalit K Jha. Washington: An Indian-American pharmaceutical billionaire was today charged with leading a nationwide conspiracy in the US by ...
Read more: Indian-American billionaire charged with leading pharmaceutical fraud scheme in US

Pharma Reviews: Ensuring Ease Of Doing Business In Himachal

Baddi has become a major manufacturing hub for Indian and multinational pharma companies. Do you have any other such project to promote ...
Read more: Ensuring Ease Of Doing Business In Himachal

Pharma Reviews: 'Pharmacy course syllabus should be reworked'

He said the Pharmacy Council of India in 2014 had focused making changes in the curriculum to meet the requirements of the pharma industry and ...
Read more: 'Pharmacy course syllabus should be reworked'

Pharma Reviews: Piramal Pharma Solutions bags CPhI Pharma Award

Indian pharma company Piramal Pharma Solutions (PPS) has won the 'Regulatory Procedures and Compliance' award at the prestigious CPhI ...
Read more: Piramal Pharma Solutions bags CPhI Pharma Award

Pharma Reviews: Indian-American billionaire charged with pharma fraud scheme in US

An Indian-American pharmaceutical billionaire was today charged with leading a nationwide conspiracy in the US by bribing doctors to over- prescribe ...
Read more: Indian-American billionaire charged with pharma fraud scheme in US

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s important efforts to address the opioid crisis

Today the Administration took a historic step to direct additional resources to help address the staggering human and economic toll created by the epidemic of opioid addiction.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s important efforts to address the opioid crisis

Pharma Reviews: China's maiden billion-dollar takeover of an Indian pharma giant

Creating a new chapter in the history of China and Indian pharmaceutical industry, China's drug giant Fosun Pharma has acquired approximately 74 ...
Read more: China's maiden billion-dollar takeover of an Indian pharma giant

Pharma Reviews: Pharmac India to take place from Nov 7 to 9 in Gujarat

Pharmac India to take place from Nov 7 to 9 in Gujarat ... to the pharma industry- Indian Pharma Machinery Manufacturers' Association (IPMMA).
Read more: Pharmac India to take place from Nov 7 to 9 in Gujarat

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives

Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives

Product Recall Alerts: Two Companies Announces Recalls, Withdrawal

The affected products were distributed to hospitals nationwide. ... According to the FDA withdrawal alert, Octapharma has not received any reports of ...
Read more: Two Companies Announces Recalls, Withdrawal

Pharma Reviews: Assam CM Sonowal woos investors

Assam Industries Minister Chandra Mohan Patowary said, "I will personally ... There is also a proposal to set up a 120-acre Pharmaceutical Park at ...
Read more: Assam CM Sonowal woos investors

Pharma Reviews: Eyeing Beaten Down Indian Pharma Stocks? Macquarie Has A List For You

Brokerage house Macquarie initiated coverage on the Indian pharmaceuticals sector with a 'cautious stance'. It believes the drug makers remain ...
Read more: Eyeing Beaten Down Indian Pharma Stocks? Macquarie Has A List For You

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance medical device innovation and help patients gain faster access to beneficial technologies

Enabling patients and providers to have efficient access to new and innovative medical products that meet the FDA’s gold standard for safety and effectiveness is a core part of our mission. We’re advancing these goals as part of the Medical Innovation Access Plan that I announced earlier this year. While we’ve unveiled parts of that plan already, we’ll be releasing its full detail shortly. As one part of that effort, we’re announcing some additional steps we’re taking right now to promote beneficial medical device innovation.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance medical device innovation and help patients gain faster access to beneficial technologies

Pharma Reviews: Indian pharma miffed with uncertainty, pricing issues

On October 20th the ministry of chemicals and fertilizers issued a press note in what seems an attempt to allay industry fears on the issue of price ...
Read more: Indian pharma miffed with uncertainty, pricing issues

Pharma Reviews: News Live: Congress demands court-monitored probe, FIR against BJP in Gujarat

The National Company Law Tribunal (NCLT) today adjourned the hearing of ... The Securities and Exchange Board of India (SEBI) is planning to allow ...
Read more: News Live: Congress demands court-monitored probe, FIR against BJP in Gujarat

Pharma Reviews: Top 7 stocks from Rakesh Jhunjhunwala's portfolio which rose 100-300% in 2017

He expects pharmaceutical sector in India to grow at 15 percent every year and believes large pharma businesses in India will do well regardless of ...
Read more: Top 7 stocks from Rakesh Jhunjhunwala's portfolio which rose 100-300% in 2017

Pharma Reviews: When pharma pricing regulator turned bat-bully; NPPA price capping shook industry, now here is ...

The pharma-pricing regulator's recent tactics have temporarily stalled the exit of high-end medical devices from India, but the arm-twisting does little to ...
Read more: When pharma pricing regulator turned bat-bully; NPPA price capping shook industry, now here is ...

Pharma Reviews: Drug MNCs lobby against price cuts of stents & knee implants

ET has learnt that representatives of global medical device makers and pharma companies have met with various Indian government officials to ...
Read more: Drug MNCs lobby against price cuts of stents & knee implants

US FDA News: FDA warns Magellan Diagnostics of significant violations of the law as part of investigation into lead testing issues

Today the U.S. Food and Drug Administration issued a warning letter to Magellan Diagnostics Inc. for several violations of federal law, including marketing significantly modified versions of two of its blood lead testing systems without the FDA’s required clearance or approval and failing to submit medical device reports to the FDA after becoming aware of customer complaints involving discrepancies in blood lead test results.
Read more: FDA warns Magellan Diagnostics of significant violations of the law as part of investigation into lead testing issues

US FDA News: Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal

Suspend further administration of octagam 10% from production lots K724B8541 and K725A8541.
Read more: Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal

Pharma Reviews: 'Government plan may bring non-essential drugs under price control'

It has potential to bring non- essential drugs under price control, reduce competition and compromise growth,” Indian Pharmaceutical Alliance (IPA) ...
Read more: 'Government plan may bring non-essential drugs under price control'

Pharma Reviews: Nursing Back to Health

“Indian pharma companies are improving their R&D and shifting focus to niche areas such as biosimilars derma, injectables and complex generics ...
Read more: Nursing Back to Health

Pharma Reviews: News Live: Centre to start sustained dialogue in J&K, says Rajnath Singh

It has potential to bring non-essential drugs under price control, reduce competition and compromise growth," Indian Pharmaceutical Alliance (IPA) ...
Read more: News Live: Centre to start sustained dialogue in J&K, says Rajnath Singh

Pharma Reviews: 'Govt plan may bring non-essential drugs under price control'

It has potential to bring non- essential drugs under price control, reduce competition and compromise growth," Indian Pharmaceutical Alliance (IPA) ...
Read more: 'Govt plan may bring non-essential drugs under price control'

Pharma Reviews: Medicine sales grow despite price control

On the other hand, the overall Indian pharmaceutical market, which includes medicines outside price control, recorded a growth of 38% from Rs 6,636 ...
Read more: Medicine sales grow despite price control

Pharma Reviews: Pharma industry seeks extension as skill certification cut-off looms

According to Indian drug industry experts, “It is not possible for the LSSSDC to certify personnel employed in all pharmaceuticals units for around 57 ...
Read more: Pharma industry seeks extension as skill certification cut-off looms

Pharma Reviews: Price control on drugs is lazy thinking

R&D spends by Indian pharma companies are already low, at 8-10% of their sales revenue, when compared to a figure of 20% for multinationals.
Read more: Price control on drugs is lazy thinking

US FDA News: Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination

Administration of a drug product, intended to be sterile, that may contain microbial contamination has the potential to result in serious adverse events which may include life-threatening infections. Posted 10/21/2017
Read more: Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination

Pharma Reviews: This week in pharma: Quiet Diwali for stocks as analysts predict challenging Q2

Pharma stocks this Diwali week were largely quiet as analysts remained ... it got permission from Indian drug regulator for its blockbuster anti-diabetic drug ... In a major consolidation in generics pharma industry in US - Amneal and ...
Read more: This week in pharma: Quiet Diwali for stocks as analysts predict challenging Q2

Pharma Reviews: Sustaining generic drug manufacturing quality to propel growth of Indian pharma: Assocham & UL ...

Indian pharma industry will be benefited and be able to garner revenues, with the highly profitable drugs going off-patent in the coming years.
Read more: Sustaining generic drug manufacturing quality to propel growth of Indian pharma: Assocham & UL ...

Pharma Reviews: Curriculum of pharma education in India need to focus on industry based: Ranjit Madan

The curriculum of pharmacy education in India should have subjects like industry based practical skills so as to enable students to look for gainful ...
Read more: Curriculum of pharma education in India need to focus on industry based: Ranjit Madan

Pharma Reviews: Pharma firms bank on complex generics to push earnings growth

“This would be significant for the Indian generic drug industry. People benefit tremendously from complex generics such as inhalers. These are value ...
Read more: Pharma firms bank on complex generics to push earnings growth

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D. on medical device manufacturing recovery in Puerto Rico

Statement by FDA Commissioner Scott Gottlieb, M.D. on medical device manufacturing recovery in Puerto Rico
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D. on medical device manufacturing recovery in Puerto Rico

US FDA News: Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) by St. Jude Medical: FDA Safety Communication - Batteries May Fail Earlier Than Expected

UPDATED 10/19/2017. St. Jude Medical notified physicians of the Battery Performance Alert (BPA), a new tool that detects and notifies physicians of abnormal battery performance that may lead to premature battery depletion.
Read more: Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) by St. Jude Medical: FDA Safety Communication - Batteries May Fail Earlier Than Expected

Pharma Reviews: Double-Digit Growth Eluding Drugmakers Worrying, Says Pfizer India Ex-Chief

The current growth of the pharmaceutical industry is worrying as the sector is not touching double-digit growth, Kewal Handa, former managing ...
Read more: Double-Digit Growth Eluding Drugmakers Worrying, Says Pfizer India Ex-Chief

US FDA News: FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma

The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the FDA and the first for certain types of non-Hodgkin lymphoma (NHL).
Read more: FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma

Pharma Reviews: The next frontier for CMOs

In the pharmaceutical industry parlance, a contract manufacturing .... operating and human resource costs of manufacturing hubs like China and India.
Read more: The next frontier for CMOs

Pharma Reviews: One in Four of Top 100 Richest Indians are NRI

Nearly one in eight richest Indians are in the pharmaceutical sector, followed by 10 percent in fast moving consumer goods and chemicals and ...
Read more: One in Four of Top 100 Richest Indians are NRI

Pharma Reviews: M&A deals in pharma sector decline in 2017 amid tough business conditions

Pricing pressure and regulatory interventions in key markets of India and the US have resulted in a decline in number of pharma M&A deals.
Read more: M&A deals in pharma sector decline in 2017 amid tough business conditions

Pharma Reviews: Narendra Modi government's move to cap prices of medical devices rankles industry; here is why

As per the government's Make-in-India survey, the medical devices industry in India ... This move caused alarm among the Indian drug manufactures.
Read more: Narendra Modi government's move to cap prices of medical devices rankles industry; here is why

Pharma Reviews: Popular antacid samples fail quality tests, company claims they were counterfeits

NEW DELHI: India's apex drug regulator has flagged Indian drug major Sun Pharma's popular medicine brands 'Pantocid' and 'Pantocid DSR' for ...
Read more: Popular antacid samples fail quality tests, company claims they were counterfeits

Pharma Reviews: Non-essential drugs may be next in line to come under price control

The Indian Pharmaceutical Alliance (IPA), which represents national pharmaceutical companies, is said to have noted such revisions are being ...
Read more: Non-essential drugs may be next in line to come under price control

Pharma Reviews: Samvat 2074: Jhunjhunwala says mkt staring at 'very long' bull run; bets on complex generics in ...

For the sector, he said, everything that could go wrong has already gone wrong and the worst is behind. He expects pharmaceutical sector in India to ...
Read more: Samvat 2074: Jhunjhunwala says mkt staring at 'very long' bull run; bets on complex generics in ...

Pharma Reviews: After stents and knee implants, government now plans to put a price cap on non-essential drugs

The Indian Pharmaceutical Alliance (IPA), a grouping of leading domestic drug companies, said such an amendment would "kill competition and ...
Read more: After stents and knee implants, government now plans to put a price cap on non-essential drugs

Pharma Reviews: Cadila, Aurobindo to lead Q2 growth in pharma space

Cadila, Aurobindo to lead Q2 growth in pharma space ... business is expected to lead to a strong sequential revenue growth for Indian pharma majors. Brokerages believe that pharma business of domestic focussed companies could ...
Read more: Cadila, Aurobindo to lead Q2 growth in pharma space

Pharma Reviews: Glenmark's Glenn Saldanha takes over as president of pharma lobby group IPA

... of Glenmark Pharmaceuticals has taken over as the President of domestic pharmaceutical lobby group Indian Pharmaceutical Alliance (IPA).
Read more: Glenmark's Glenn Saldanha takes over as president of pharma lobby group IPA

Pharma Reviews: ICICI Securities projects revenue growth of 6.3% of pharma segment in Q2

Indian pharma companies set to achieve recovery in revenue for the quarter ended September 2017 on account of improvement in domestic ...
Read more: ICICI Securities projects revenue growth of 6.3% of pharma segment in Q2

Pharma Reviews: Chini-Chini Buy, Buy

Chakraborty's company, Zenith Finesse India Pvt. Ltd, imported corporate gift ... at a lesser price in another country - on the pharmaceutical industry.
Read more: Chini-Chini Buy, Buy

Pharma Reviews: Base Erosion and Profit Shifting guidelines stump MNCs

MUMBAI: A multinational pharma company moved about 70 employees from its research and development (R&D) facility in India to Switzerland last ...
Read more: Base Erosion and Profit Shifting guidelines stump MNCs

Pharma Reviews: This week in pharma: Sun Pharma get EIR for Dadra plant, Lupin acquires Symbiomix Therapeutics

Sun Pharma, India's largest drug maker announced that it received establishment inspection report (EIR) from US FDA for the company's Dadra ...
Read more: This week in pharma: Sun Pharma get EIR for Dadra plant, Lupin acquires Symbiomix Therapeutics

Pharma Reviews: Indian pharma industry sees need for govt support to propel it up value chain

It is high time India pharma industry sets a criteria in quality production for global drug sector to emulate, said Sunil Attavar, president, Karnataka ...
Read more: Indian pharma industry sees need for govt support to propel it up value chain

US FDA News: FDA clears new robotically-assisted surgical device for adult patients

Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery.
Read more: FDA clears new robotically-assisted surgical device for adult patients

Pharma Reviews: How India Inc is losing its cybersecurity war

A few years ago, US intelligence agency NSA had picked up the trend of Chinese hackers targeting Indian pharmaceutical and IT companies and ...
Read more: How India Inc is losing its cybersecurity war

Pharma Reviews: Indian pharma grows at mere 1% in Sept quarter, recovery from GST disruption slow

Indian pharmaceutical market (IPM) continued to be sluggish even in September month as the recovery from the supply chain disruption caused due ...
Read more: Indian pharma grows at mere 1% in Sept quarter, recovery from GST disruption slow

US FDA News: California dietary supplement maker, Custompax prohibited from manufacturing

A California dietary supplement manufacturer recently was ordered by a federal court to stop selling its products until the company comes into compliance with the U.S. Food and Drug Administration’s dietary supplement manufacturing regulations and other requirements listed in a consent decree.
Read more: California dietary supplement maker, Custompax prohibited from manufacturing

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D. on Baxter manufacturing recovery in Puerto Rico

Statement by FDA Commissioner Scott Gottlieb, M.D. on Baxter manufacturing recovery in Puerto Rico
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D. on Baxter manufacturing recovery in Puerto Rico

Pharma Reviews: NovaLead Pharma Receives Frost & Sullivan's Indian Drug Repurposing Technology Innovation ...

In 2015, NovaLead Pharma had received the Best Innovation Company BIRAC award from Department of Biotechnology, Government of India.
Read more: NovaLead Pharma Receives Frost & Sullivan's Indian Drug Repurposing Technology Innovation ...

US FDA News: FDA clears first 7T magnetic resonance imaging device

Today, the U.S. Food and Drug Administration cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic field strength available for use in the United States. The Magentom Terra is the first 7T MRI system cleared for clinical use in the United States.
Read more: FDA clears first 7T magnetic resonance imaging device

Pharma Reviews: Devinder Pal, Pharmabiz advisory board member & past president IPA no more

DEVINDER-PAL.jpg Pharmabiz board member Devinder Pal, who was also the past president, Indian Pharmaceutical Association, passed away on ...
Read more: Devinder Pal, Pharmabiz advisory board member & past president IPA no more

Pharma Reviews: Less penetrated consumer discretionaries to exhibit faster growth: Prashant Jain, HDFC AMC

How do you expect the earning season and the market to be? ... a process which I am sure Indian pharma companies will sort out; but two, they are ...
Read more: Less penetrated consumer discretionaries to exhibit faster growth: Prashant Jain, HDFC AMC

Pharma Reviews: Pharma Stocks Are A 'Good Contra-Bet', Says Aditya Birla Sun Life

It is a good time to increase exposure to India's pharmaceutical sector, according to Aditya Birla Sun Life Mutual Fund. Drug makers that are starting to ...
Read more: Pharma Stocks Are A 'Good Contra-Bet', Says Aditya Birla Sun Life

Pharma Reviews: Scientists are being anti-development: EPTRI

By saying so it is opposing any development of pharma industry in Telangana. ... KBabu Rao, retired chief scientist of the Indian Institute of Chemical ...
Read more: Scientists are being anti-development: EPTRI

Pharma Reviews: Shore up supply of critical drugs, govt tells industry

The meeting organized by the DoP on Wednesday was attended by representatives of the Indian Drug Manufacturers' Association (IDMA) and the ...
Read more: Shore up supply of critical drugs, govt tells industry

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D. on new steps by FDA to advance patient engagement in the agency’s regulatory work

The Food and Drug Administration is hosting a pioneering event today: the first meeting of the Patient Engagement Advisory Committee or PEAC. It’s a significant step forward in the FDA’s efforts to broaden its engagement with patients – and to deepen the involvement of patients in our regulatory activities.
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D. on new steps by FDA to advance patient engagement in the agency’s regulatory work

Pharma Reviews: New drugs sold in India must include Indians in clinical trials: Govt

The CDSCO (Central Drugs Standard Control Organisation) has decided to make it mandatory for pharma companies to include Indian patients in ...
Read more: New drugs sold in India must include Indians in clinical trials: Govt

Pharma Reviews: Hyderabad Pharma city to reduce import dependency

Briefing media on the developments and status of the pharma city on Tuesday, Telangana Industries minister K T Rama Rao said, “Indian industry is ...
Read more: Hyderabad Pharma city to reduce import dependency

Pharma Reviews: Fullife Triggers a Radical Shift Towards Lifestyle OTC Drugs Using the Latest Effervescent Delivery ...

Mumbai-based Fullife Healthcare Private Limited is ushering in a paradigm shift in India's lifestyle drug market, using innovative effervescent products.
Read more: Fullife Triggers a Radical Shift Towards Lifestyle OTC Drugs Using the Latest Effervescent Delivery ...

Pharma Reviews: 'Pharma exports declined by 4% up to Aug on pricing pressure'

'Pharma exports declined by 4% up to Aug on pricing pressure' ... Hyderabad: Pharma exports from India registered a negative growth of 4 per ... India (Pharmexcil), a Ministry of Commerce and Industry body, the pharma exports to ...
Read more: 'Pharma exports declined by 4% up to Aug on pricing pressure'

Pharma Reviews: Piramal Pharma announces expansion of API mfg facilities

Mumbai, Oct 10 (PTI) Piramal Pharma Solutions (PPS), a contract development ... out of Ennore in India through additions of GMP kilo labs and a pilot plant. ... The company, part of Piramal Enterprises Ltd. (PEL), will also expand ...
Read more: Piramal Pharma announces expansion of API mfg facilities

Pharma Reviews: India is second largest market for pharma, biotech workforce: Report

With 13.7 per cent contribution to the global pharmaceuticals and biotechnology workforce, India has emerged as the second largest market for the ...
Read more: India is second largest market for pharma, biotech workforce: Report

Pharma Reviews: 5 things to expect from Q2 earnings of drug makers

Cadila Healthcare, Dr.Reddy's, Aurobindo are the companies to watch out for with half of their revenues coming from US. For Sun Pharma, India's ...
Read more: 5 things to expect from Q2 earnings of drug makers

Pharma Reviews: Firms may have to print 'ex-factory' price of drugs

The proposal has perturbed pharmaceutical companies as it will put their ... MRP," said DG Shah, secretary general, Indian Pharmaceutical Alliance.
Read more: Firms may have to print 'ex-factory' price of drugs

Pharma Reviews: Market Live: Nifty holds 10K, Midcap outperforms Sensex; Lupin, Biocon rally

Modi, they said, at the meeting stressed that India in the energy sector is ... The US Food and Drug Administration has issued a complete response ...
Read more: Market Live: Nifty holds 10K, Midcap outperforms Sensex; Lupin, Biocon rally

Pharma Reviews: Indian Pharmaceutical Exports Fell Till August Due To Pricing Pressure

Pharmaceutical exports from India fell 4 percent during the first five months of the current fiscal due to increased regulatory concerns and pricing ...
Read more: Indian Pharmaceutical Exports Fell Till August Due To Pricing Pressure

Pharma Reviews: 'Pharma exports declined by 4% up to Aug on pricing pressure'

Hyderabad, Oct 9 () Pharma exports from India registered a negative growth of 4 ... of India (Pharmexcil), a Ministry of Commerce and Industry body, the pharma ... To some extent import alerts (by US FDA on Indian plants), regulatory ...
Read more: 'Pharma exports declined by 4% up to Aug on pricing pressure'

Pharma Reviews: 'Pharma exports declined by 4% up to August on pricing pressure'

Pharma exports from India registered a negative growth of 4 percent during the ... of India (Pharmexcil), a Ministry of Commerce and Industry body, the pharma ... To some extent import alerts (by US FDA on Indian plants), regulatory ...
Read more: 'Pharma exports declined by 4% up to August on pricing pressure'

Pharma Reviews: 'Pharma exports declined by 4% up to Aug on pricing pressure'

'Pharma exports declined by 4% up to Aug on pricing pressure' ... Hyderabad, Oct 9 Pharma exports from India registered a negative growth of 4 per ... of India (Pharmexcil), a Ministry of Commerce and Industry body, the pharma ...
Read more: 'Pharma exports declined by 4% up to Aug on pricing pressure'

Pharma Reviews: Generic drug approvals in US hit record high in FY17

Among Indian firms, the pace of drug approvals was strong for Aurobindo Pharma Ltd, Cadila Healthcare Ltd and Lupin Ltd. Total filings of abbreviated ...
Read more: Generic drug approvals in US hit record high in FY17

Pharma Reviews: India plans to lessen its drug reliance on China

Currently, India gets 70-80% of its medicines and medical devices supplies, including raw material for pharmaceuticals (Active Pharmaceutical ...
Read more: India plans to lessen its drug reliance on China

Pharma Reviews: India plans to lessen its drug reliance on China

Currently, API accounts for less than 10% of India's over Rs 1 lakh crore pharmaceutical industry. However, India was once a favoured destination for ...
Read more: India plans to lessen its drug reliance on China

US FDA News: A1 Slim by Kiriko : Recall - Undeclared Drug Ingredients

Product tainted with sibutramine, phenolphthalein and N-Desmethyl sibutramine.
Read more: A1 Slim by Kiriko : Recall - Undeclared Drug Ingredients

Pharma Reviews: Pharma Newsletter – October 02 to October 06, 2017

This week, “Granules India informed that the USFDA has issued ... a 50:50 JV between the company and Ajinimoto OmniChem N.V. at Vizag, Andhra ...
Read more: Pharma Newsletter – October 02 to October 06, 2017

Pharma Reviews: Modi's diaspora nationalism is not anti-globalisation: Aseema Sinha

You have undertaken a detailed study of India's textile and pharma industries in the context of liberalisation. In the process you have touched upon ...
Read more: Modi's diaspora nationalism is not anti-globalisation: Aseema Sinha

Pharma Reviews: Profits from Copaxone generics to help strengthen balance sheet, expansion: Natco CEO

Copaxone is by far the biggest ever generic approval in 2017 for Indian generic pharma industry in US. The drug is the most prescribed multiple ...
Read more: Profits from Copaxone generics to help strengthen balance sheet, expansion: Natco CEO

Pharma Reviews: BSE Healthcare Index dips by 8.9% in first 9 months of 2017, Sensex moves up by 17.6%

BSE Healthcare (BSEHC) index of 70 leading healthcare companies ... For the first half ended June 2017, Indian pharma companies received final ...
Read more: BSE Healthcare Index dips by 8.9% in first 9 months of 2017, Sensex moves up by 17.6%

US FDA News: FDA approves implantable device to treat moderate to severe central sleep apnea

The U.S. Food and Drug Administration today approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remedē System is an implantable device that stimulates a nerve located in the chest that is responsible for sending signals to the diaphragm to stimulate breathing.
Read more: FDA approves implantable device to treat moderate to severe central sleep apnea

Product Recall Alerts: Combatting counterfeiting with Authentication

However, regulatory requirements for serialisation in the pharmaceutical industry, such as the EU ... and pre-empt any potential issues such as product recalls, even alerting consumers that scan the product code using their phone.
Read more: Combatting counterfeiting with Authentication

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s continued assistance following the natural disaster in Puerto Rico

FDA continues extensive efforts to provide direct assistance to the residents of Puerto Rico following Hurricanes Irma and Maria, and is taking new steps to mitigate the impact of these twin disasters on the island’s vibrant medical product manufacturing sector. Our top priority is the people of Puerto Rico.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s continued assistance following the natural disaster in Puerto Rico

US FDA News: Intralipid 20 Percent IV Fat Emulsion by Baxter: Recall - One Shipment of Product Exposed to Subfreezing Temperatures

When subjected to freezing, emulsion droplets will increase in size, forming aggregates that can block pulmonary circulation/lead to serious adverse health consequences that can be life-threatening.
Read more: Intralipid 20 Percent IV Fat Emulsion by Baxter: Recall - One Shipment of Product Exposed to Subfreezing Temperatures

US FDA News: FDA awards six grants for natural history studies in rare diseases

The U.S. Food and Drug Administration today announced it has awarded six new research grants for natural history studies in rare diseases. The aim of the research is to inform medical product development by better understanding how specific rare diseases progress over time. One potential application of these studies is the opportunity to eventually use natural history models to augment the need for placebo arms in studies of drugs that target very rare disease, where trial recruitment can be challenging.
Read more: FDA awards six grants for natural history studies in rare diseases

US FDA News: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases

The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country.
Read more: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases

Pharma Reviews: Indian Institute of Foreign Trade concludes summer placements

Indian Institute of Foreign Trade (IIFT) has completed its summer ... Leading brands in Pharma sector such as Medtronic, Sun Pharma, Boston ...
Read more: Indian Institute of Foreign Trade concludes summer placements

US FDA News: FDA approves first test for screening Zika virus in blood donations

The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors.
Read more: FDA approves first test for screening Zika virus in blood donations

Pharma Reviews: Govt to hold talks on impact of capping trade margin of drugs

The meeting will be attended by representatives of pharma industry associations including Indian Drug Manufacturers' Association (IDMA), Indian ...
Read more: Govt to hold talks on impact of capping trade margin of drugs

Pharma Reviews: Gland Pharma to leverage Fosun's strengths for growth

Gland Pharma will also increase its product portfolios in India and regulated ... The company is already working on the biosimilar of blockbuster ...
Read more: Gland Pharma to leverage Fosun's strengths for growth

Pharma Reviews: Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 bn

Chinese drug firm Fosun Pharma has acquired approximately 74 percent in ... In the regulatory filing, Fosun Pharma and Fosun International said ... the relevant Indian foreign investment policies," Fosun Pharma said at that time.
Read more: Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 bn

Pharma Reviews: India's NSE index energy, metals companies to post earnings jump - Deutsche Bank

Muted U.S. healthcare business and pricing pressure could continue to hurt Indian pharma companies such as Sun Pharmaceutical Industries, ...
Read more: India's NSE index energy, metals companies to post earnings jump - Deutsche Bank

Pharma Reviews: India's 100 Richest 2017: Bitter Pill To Swallow For India's Pharma Companies

In 2014, Dilip Shanghvi, founder of Sun Pharmaceutical Industries, India's most valuable drug company, became the country's second-richest person, ...
Read more: India's 100 Richest 2017: Bitter Pill To Swallow For India's Pharma Companies

Pharma Reviews: Fosun strikes fresh deal to buy Gland Pharma

Under the revised deal, the Indian promoters, Ravi Penmetsa and his father P V N Raju, will hold 26% and remain on the board of the company for at ...
Read more: Fosun strikes fresh deal to buy Gland Pharma

Pharma Reviews: Fosun Pharma Completes Largest Ever Chinese Acquisition In India For $1.09 Billion

New Delhi: Chinese drug firm Fosun Pharma has acquired approximately 74 per cent in Hyderabad-based Gland Pharma at a valuation of not more ...
Read more: Fosun Pharma Completes Largest Ever Chinese Acquisition In India For $1.09 Billion

Pharma Reviews: Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billion

Shanghai Fosun Pharmaceutical (Group) Co Ltd had earlier in July last ... amid heightened tensions between India and China over border dispute.
Read more: Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billion

Pharma Reviews: Eris Lifesciences Limited acquires nutraceuticals maker UTH Healthcare

Eris Lifesciences Limited, one of the fastest growing companies in the chronic category of the Indian Pharmaceuticals Market (IPM), has acquired the ...
Read more: Eris Lifesciences Limited acquires nutraceuticals maker UTH Healthcare

Pharma Reviews: Indian pharmaceutical industry growth challenges continues: ICRA

Indian pharmaceutical industry is likely to register moderate growth on the back of slowing growth from US given the relatively moderate proportion of ...
Read more: Indian pharmaceutical industry growth challenges continues: ICRA

US FDA News: Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin (TMV) Formulation: FDA Statement - Case of Hemorrhagic Occlusive Retinal Vasculitis

Prophylactic use of intraocular vancomycin, alone or in a compounded drug, during cataract surgery is generally not recommended because of the risk of HORV.
Read more: Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin (TMV) Formulation: FDA Statement - Case of Hemorrhagic Occlusive Retinal Vasculitis

US FDA News: Infant Sleep Positioners: FDA Warning - Risk of Suffocation

FDA reminding parents and caregivers not to put babies in sleep positioners. These products, sometimes also called “nests” or “anti-roll” products, can cause suffocation that can lead to death.
Read more: Infant Sleep Positioners: FDA Warning - Risk of Suffocation

Pharma Reviews: Indian drugmakers' revenue growth in US may cool off to 7-10% over 3 years: ICRA

The domestic market considered to be the safe bet for Indian generic drug makers with favorable macro-economic indicators and predictable ...
Read more: Indian drugmakers' revenue growth in US may cool off to 7-10% over 3 years: ICRA

Pharma Reviews: Pharma stocks extend recent gains

Pharma stocks gained for the third straight day. ... September saw a sustained expansion in the Indian manufacturing sector, supported by increases in ...
Read more: Pharma stocks extend recent gains

Pharma Reviews: Fosun pharma now looking onto acquiring Symbiotec

Weeks after Chinese pharmaceutical giant Fosun tweaked its acquisition of ... Shanghai-based Fosun Pharmaceutical is in talks to acquire the ... plans on account of rising concerns over Chinese influence on India's drug industry.
Read more: Fosun pharma now looking onto acquiring Symbiotec

Pharma Reviews: Open to partnerships that will help us increase access: Eisai Pharmaceuticals India's Sanjit Singh ...

India offers a tremendous growth potential and from a future growth perspective, the company is open to partnerships for increasing access and ...
Read more: Open to partnerships that will help us increase access: Eisai Pharmaceuticals India's Sanjit Singh ...

Pharma Reviews: SEZ for only Indian companies in Taskhent soon

Plans are afoot for setting up an SEZ in Uzbekistan especially for Indian pharmaceutical companies, which are keen to set up manufacturing facilities ...
Read more: SEZ for only Indian companies in Taskhent soon

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s Adverse Event Reporting System (FAERS) and new search tool

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s Adverse Event Reporting System (FAERS) and new search tool
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s Adverse Event Reporting System (FAERS) and new search tool

Pharma Reviews: Icra sees moderate growth in pharma industry

Research and rating agency Icra said Indian pharmaceutical industry was likely to register a moderate growth on the back of slowing growth from the ...
Read more: Icra sees moderate growth in pharma industry

Pharma Reviews: How global investors view the Indian stock market

The Indian pharma sector represents the ability of new firms to take on established drug manufacturers, patent new drugs and compete in the global ...
Read more: How global investors view the Indian stock market

Pharma Reviews: Exporters feel pinch of delayed GST refunds

According to estimates of the Federation of Indian Export Organizations ... Merchant exporters in the pharma industry are also facing an estimated ...
Read more: Exporters feel pinch of delayed GST refunds

Pharma Reviews: Statspeak: Pharma Watch

EY's Digital Maturity Index discloses that Indian pharmaceutical companies lag behind in their digital journey compared to their global counterparts.
Read more: Statspeak: Pharma Watch

Pharma Reviews: After Gland, Chinese pharma giant Fosun eyes API maker Symbiotec

MUMBAI: Weeks after Chinese pharmaceutical giant Fosun tweaked its ... is a renewed interest among Chinese drug manufacturers to look at Indian ...
Read more: After Gland, Chinese pharma giant Fosun eyes API maker Symbiotec

Pharma Reviews: Govt may raise licence fees of global drug makers by five times

D.G. Shah, secretary general of the Indian Pharmaceutical Alliance (IPA) said the move is consistent with the government policy on indigenisation.
Read more: Govt may raise licence fees of global drug makers by five times